Home › Diffuse Large B-Cell Lymphoma › Georgia › Augusta
Diffuse Large B-Cell Lymphoma clinical trials in Augusta, GA
4 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Augusta University, Augusta
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RecruitingPhase 2
- Augusta University Georgia Cancer Center, Augusta
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Augusta University Medical Center, Augusta
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Georgia Cancer Center at Augusta University, Augusta
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY21 studies
- Baldwin Park, CA19 studies
- Chicago, IL18 studies
- Houston, TX17 studies
- Los Angeles, CA17 studies
- Milwaukee, WI16 studies
- Boston, MA16 studies
- Philadelphia, PA15 studies
- Portland, OR15 studies
- Durham, NC14 studies
- Nashville, TN14 studies
- Dallas, TX13 studies
Other studies in Augusta
- Acute Myeloid Leukemia10 studies
- Ovarian Cancer8 studies
- Endometrial Cancer7 studies
- Cancer (all types)7 studies
- Breast Cancer5 studies
- Blood Cancers5 studies
- Sickle Cell Disease5 studies
- Cervical Cancer4 studies
- Burkitt Lymphoma4 studies
- Non-Hodgkin Lymphoma4 studies
- Chronic Myeloid Leukemia4 studies
- Myasthenia Gravis4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.